Outcome of heart transplantation in patients previously infected with hepatitis C virus

被引:14
作者
Castella, M [1 ]
Tenderich, G [1 ]
Koerner, MM [1 ]
Arusoglu, L [1 ]
El-Banayosy, A [1 ]
Schulz, U [1 ]
Schulze, B [1 ]
Minami, K [1 ]
Koerfer, R [1 ]
机构
[1] Ruhr Univ Bochum, Heart Ctr N Rhine Westphalia, Dept Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany
关键词
D O I
10.1016/S1053-2498(00)00198-4
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The lack of knowledge about the course of hepatitis C virus infection (HCV) before heart transplantation (HTx) prompted us to describe our experience with 4 such patients who presented with positive HCV serology before surgery. Two experienced non-liver related deaths at 3.5 and 5 years after HTx, and none of the patients developed signs of hepatic insufficiency during the follow-up (mean 3.8 years). Tests for HCV antibodies were frequently negative, whereas viral RNA was detected in 81% of the measurements, showing that virus detection techniques seem to be more sensitive than serology techniques in detecting HCV infection in this group of patients. Although immunosuppression promotes active HCV replication, it does not seem to change the chronic features of HCV infection during the first years in patients with good liver function.
引用
收藏
页码:595 / 598
页数:4
相关论文
共 11 条
[1]
HEPATITIS-C INFECTION IN PATIENTS WITH PRIMARY HYPOGAMMAGLOBULINEMIA AFTER TREATMENT WITH CONTAMINATED IMMUNE GLOBULIN [J].
BJORO, K ;
FROLAND, SS ;
YUN, ZB ;
SAMDAL, HH ;
HAALAND, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (24) :1607-1611
[2]
Long-term outcome of hepatitis C virus infection after liver transplantation [J].
Boker, KHW ;
Dalley, G ;
Bahr, MJ ;
Maschek, H ;
Tillmann, HL ;
Trautwein, C ;
Oldhaver, K ;
Bode, U ;
Pichlmayr, R ;
Manns, MP .
HEPATOLOGY, 1997, 25 (01) :203-210
[3]
Outcome of long-term ribavirin therapy for recurrent hepatitis C after liver transplantation [J].
Cattral, MS ;
Hemming, AW ;
Wanless, IR ;
Al Ashgar, H ;
Krajden, M ;
Lilly, L ;
Greig, PD ;
Levy, GA .
TRANSPLANTATION, 1999, 67 (09) :1277-1280
[4]
DIAGNOSIS OF HEPATITIS-C VIRUS (HCV) INFECTION USING AN IMMUNODOMINANT CHIMERIC POLYPROTEIN TO CAPTURE CIRCULATING ANTIBODIES - REEVALUATION OF THE ROLE OF HCV IN LIVER-DISEASE [J].
CHIEN, DY ;
CHOO, QL ;
TABRIZI, A ;
KUO, C ;
MCFARLAND, J ;
BERGER, K ;
LEE, C ;
SHUSTER, JR ;
NGUYEN, T ;
MOYER, DL ;
TONG, M ;
FURUTA, S ;
OMATA, M ;
TEGTMEIER, G ;
ALTER, H ;
SCHIFF, E ;
JEFFERS, L ;
HOUGHTON, M ;
KUO, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10011-10015
[5]
Natural history of hepatitis C: Its impact on clinical management [J].
Di Bisceglie, AM .
HEPATOLOGY, 2000, 31 (04) :1014-1018
[6]
Esteban JI, 1998, CURR STUD HEMATOL BL, P102
[7]
Recurrent and new hepatitis C virus infection after liver transplantation [J].
Everhart, JE ;
Wei, YL ;
Eng, H ;
Charlton, MR ;
Persing, DH ;
Wiesner, RH ;
Germer, JJ ;
Lake, JR ;
Zetterman, RK ;
Hoofnagle, JH .
HEPATOLOGY, 1999, 29 (04) :1220-1226
[8]
Outcomes of hepatitis C positive (HCV+) heart transplant recipients [J].
Lake, KD ;
Smith, CI ;
MilfredLaForest, SK ;
Pritzker, MR ;
Emery, RW .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :581-582
[9]
THE IMPACT OF HEPATITIS-C VIRUS-INFECTION ON RENAL-ALLOGRAFT RECIPIENTS [J].
ROTH, D ;
ZUCKER, K ;
CIROCCO, R ;
DEMATTOS, A ;
BURKE, GW ;
NERY, J ;
ESQUENAZI, V ;
BABISCHKIN, S ;
MILLER, J .
KIDNEY INTERNATIONAL, 1994, 45 (01) :238-244
[10]
Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis [J].
Soto, B ;
SanchezQuijano, A ;
Rodrigo, L ;
delOlmo, JA ;
GarciaBengoechea, M ;
HernandezQuero, J ;
Rey, C ;
Abad, MA ;
Rodriguez, M ;
Gilabert, MS ;
Gonzalez, F ;
Miron, P ;
Caruz, A ;
Relimpio, F ;
Torronteras, R ;
Leal, M ;
Lissen, E .
JOURNAL OF HEPATOLOGY, 1997, 26 (01) :1-5